封面
市場調查報告書
商品編碼
2019916

2026-2034年全球神經外科醫療設備市場規模、佔有率、趨勢和成長分析報告

Global Neurosurgery Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 139 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計神經外科醫療設備市場規模將從 2025 年的 193.6 億美元成長到 2034 年的 526.5 億美元,2026 年至 2034 年的複合年成長率為 11.76%。

由於神經系統疾病和腦部相關疾病的發生率不斷上升,全球神經外科醫療設備市場正經歷強勁成長。神經外科手術中使用的醫療設備,包括手術器械、導航系統和植入,對於治療腦腫瘤、脊髓疾病和創傷性損傷等疾病至關重要。醫療技術的進步顯著提高了手術精確度和患者預後。

推動神經成長要素包括老年人口的增加(老年人易患神經系統疾病)以及微創手術技術的普及。機器人輔助手術和先進影像系統等技術創新進一步提高了神經外科手術的有效性。此外,不斷上漲的醫療成本也促進了先進醫療設備的應用。

未來,隨著持續創新和新一代外科技術的研發,市場預計將持續擴張。在新興國家,隨著醫療基礎設施的改善,成長機會也將隨之而來。隨著神經科學研究的進展,新的治療方法和醫療設備將進一步推動市場成長,並改善患者照護效果。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球神經外科醫療設備市場:依產品分類

  • 市場分析、洞察與預測
  • 神經刺激裝置
  • 介入神經放射學設備
  • 神經外科導航系統
  • 腦脊髓液(CSF)管理裝置
  • 其他

第5章 全球神經外科醫療設備市場:依應用領域分類

  • 市場分析、洞察與預測
  • 脊髓刺激療法
  • 深部腦部刺激
  • 神經科學用內視鏡

第6章 全球神經外科醫療設備市場:依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 其他

第7章 全球神經外科醫療設備市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Medtronic Plc
    • Johnson & Johnson
    • Stryker Corporation
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Ackermann Instrumente GmbH
    • Integra LifeSciences Corporation
    • Boston Scientific Corporation
    • BIOTRONIK SE & Co. KG
    • Adeor Medical AG
簡介目錄
Product Code: VMR11218387

The Neurosurgery Devices Market size is expected to reach USD 52.65 Billion in 2034 from USD 19.36 Billion (2025) growing at a CAGR of 11.76% during 2026-2034.

The global neurosurgery devices market is experiencing robust growth due to the increasing prevalence of neurological disorders and brain-related conditions. Devices used in neurosurgery, such as surgical instruments, navigation systems, and implants, are essential for treating conditions like brain tumors, spinal disorders, and traumatic injuries. Advancements in medical technology have significantly improved surgical precision and patient outcomes.

Key drivers include the growing aging population, which is more susceptible to neurological disorders, and the increasing adoption of minimally invasive surgical techniques. Technological innovations such as robotic-assisted surgeries and advanced imaging systems have further enhanced the effectiveness of neurosurgical procedures. Additionally, rising healthcare expenditure has supported the adoption of advanced medical devices.

In the future, the market is expected to expand with continuous innovation and the development of next-generation surgical technologies. Emerging economies will offer growth opportunities due to improving healthcare infrastructure. As research in neuroscience advances, new treatment approaches and devices will further drive market growth and improve patient care outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Neurostimulation Devices
  • Neurointerventional Devices
  • Neurosurgical Navigation Systems
  • Cerebral Spinal Fluid (CSF) Management Devices
  • Others

By Application

  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Neuroendoscopy

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

COMPANIES PROFILED

  • Medtronic plc, Johnson Johnson, Stryker Corporation, Abbott Laboratories, B Braun Melsungen AG, Ackermann Instrumente GmbH, Integra LifeSciences Corporation, Boston Scientific Corporation, BIOTRONIK SE Co KG, Adeor Medical AG
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROSURGERY DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Neurostimulation Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Neurointerventional Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Neurosurgical Navigation Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Cerebral Spinal Fluid (CSF) Management Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROSURGERY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Spinal Cord Stimulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Deep Brain Stimulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Neuroendoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROSURGERY DEVICES MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEUROSURGERY DEVICES MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Application
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Application
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Application
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Application
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Application
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEUROSURGERY DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Medtronic Plc
    • 9.2.2 Johnson & Johnson
    • 9.2.3 Stryker Corporation
    • 9.2.4 Abbott Laboratories
    • 9.2.5 B. Braun Melsungen AG
    • 9.2.6 Ackermann Instrumente GmbH
    • 9.2.7 Integra LifeSciences Corporation
    • 9.2.8 Boston Scientific Corporation
    • 9.2.9 BIOTRONIK SE & Co. KG
    • 9.2.10 Adeor Medical AG